BT-Sch
| Code | Size | Price |
|---|
| TAR-T30603-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Bt-sch is an imaging agent based on D1 and D2 receptors of dopamine.
CAS:
154540-50-8
Formula:
C24H23ClFNOS
Molecular Weight:
427.96
Purity:
0.98
SMILES:
CN1CCc2cc(Cl)c(O)cc2C(C1)c1ccc(SCc2ccc(F)cc2)cc1
References
1. Gerritz SW, Smith JS, Nanthakumar SS, Uehling DE, Cobb JE. Two general routes to 1,4-disubstituted-2,3,4,5-tetrahydro- 1H-3-benzazepines. Org Lett. 2000 Dec 14;2(25):4099-102. PubMed PMID: 11112653.
2. Gao X, Zhang Y, Wu G. Effects of dopaminergic agents on carrageenan hyperalgesia in rats. Eur J Pharmacol. 2000 Oct 6;406(1):53-8. PubMed PMID: 11011033.
3. Ikemoto S, Glazier BS, Murphy JM, McBride WJ. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci. 1997 Nov 1;17(21):8580-7. PubMed PMID: 9334429.
4. Fleckenstein AE, P?g?n S, Carroll FI, Kuhar MJ. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. J Pharmacol Exp Ther. 1996 Oct;279(1):200-6. PubMed PMID: 8858994.